MAPK3 and neoplasm: In addition, inhibition of the ERK1/2 pathway by U0126, a specific ERK1/2 inhibitor, could partially reverse tumor-promoting effects on proliferation, migration, and invasion caused by high TG2 expression, suggesting an involvement of the ERK1/2 pathway in regulating TG2 function in GC cells.